<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7590249" created="30/05/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7590249</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="constitutive_NF-kappa_B_activation" sem="Other">Constitutive <term id="T2" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activation</term>, enhanced <term id="A1" sem="Other">granulopoiesis</term>, and <term id="T4" lex="neonatal_lethality" sem="Other">neonatal lethality</term> in <term id="T5" lex="I_kappa_B_alpha-deficient_mice" sem="Multicellular_organism_genetically_modified"><term id="T6" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term>-deficient mice</term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="T2"/>
<clue>Constitutive NF-kappa B <clueType>activation</clueType>, enhanced granulopoiesis, and neonatal lethality <clueLoc>in I kappa B alpha-deficient mice.</clueLoc></clue>
</event>
<event id="E2">
<type class="Positive_regulation"/>
<theme idref="A1"/>
<clue>Constitutive NF-kappa B activation, <clueType>enhanced</clueType> granulopoiesis, and neonatal lethality <clueLoc>in I kappa B alpha-deficient mice.</clueLoc></clue>
<comment>NER: T3 del &quot;enhanced granulopoiesis&quot;</comment></event>
<event assertion="non-exist" id="E3">
<type class="Gene_expression"/>
<theme idref="T6"/>
<clue>Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-<clueType><cluePolarity>deficient</cluePolarity></clueType> <clueLoc>mice</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="A2" sem="Protein_family_or_group"><term id="T7" lex="transcription_factor" sem="Protein_family_or_group">Transcription factors</term> belonging to the <term id="T8" lex="NF-kappa_B_family" sem="Protein_family_or_group"><term id="T9" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> family</term></term> are controlled by <term id="T10" lex="inhibitory_I_kappa_B_protein" sem="Protein_family_or_group">inhibitory I kappa B proteins</term>, mainly <term id="T11" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> and <term id="T12" lex="I_kappa_B_beta" sem="Protein_molecule">I kappa B beta</term>.</sentence>
<event KT="Fact" id="E4">
<type class="Regulation"/>
<theme idref="A2"/>
<cause idref="T11"/>
<clue>Transcription factors belonging to the NF-kappa B family are <clueType>controlled</clueType> <linkCause>by</linkCause> <corefTheme>inhibitory I kappa B proteins</corefTheme>, mainly I kappa B alpha and I kappa B beta.</clue>
<comment>TPS: A2</comment></event>
<event KT="Fact" id="E5">
<type class="Regulation"/>
<theme idref="A2"/>
<cause idref="T12"/>
<clue>Transcription factors belonging to the NF-kappa B family are <clueType>controlled</clueType> <linkCause>by</linkCause> <corefTheme>inhibitory I kappa B proteins</corefTheme>, mainly I kappa B alpha and I kappa B beta.</clue>
</event>
<sentence id="S3">Apparently normal at birth, <term id="T13" lex="I_kappa_B_alpha-/-_mice" sem="Multicellular_organism_genetically_modified"><term id="T14" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term>-/- mice</term> exhibit severe <term id="A4" sem="Other">runting</term>, <term id="T15" lex="skin_defect" sem="Other">skin defects</term>, and extensive <term id="T16" lex="granulopoiesis" sem="Other">granulopoiesis</term> postnatally, typically <term id="A5" sem="Other">dying</term> by 8 days.</sentence>
<event id="E61">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<clue>Apparently normal at birth, <clueLoc>I kappa B alpha-/- mice</clueLoc> <clueType>exhibit</clueType> severe runting, skin defects, and extensive granulopoiesis postnatally, typically dying by 8 days.</clue>
</event>
<event id="E62">
<type class="Positive_regulation"/>
<theme idref="T15"/>
<clue>Apparently normal at birth, <clueLoc>I kappa B alpha-/- mice</clueLoc> <clueType>exhibit</clueType> severe runting, skin defects, and extensive granulopoiesis postnatally, typically dying by 8 days.</clue>
</event>
<event id="E63">
<type class="Positive_regulation"/>
<theme idref="T16"/>
<clue>Apparently normal at birth, <clueLoc>I kappa B alpha-/- mice</clueLoc> exhibit severe runting, skin defects, and <clueType>extensive</clueType> granulopoiesis postnatally, typically dying by 8 days.</clue>
</event>
<sentence id="S4"><term id="T17" lex="hematopoietic_tissue" sem="Tissue_natural">Hematopoietic tissues</term> from these <term id="T18" lex="mice" sem="Multicellular_organism_natural">mice</term> display elevated levels of both <term id="T19" lex="nuclear_NF-kappa_B" sem="Protein_molecule">nuclear <term id="T20" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term></term> and <term id="T21" lex="mRNA" sem="RNA_family_or_group">mRNAs</term> of some, but not all, genes <term id="A3" sem="RNA_family_or_group">thought to be regulated by <term id="T22" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>.</term></sentence>
<event id="E6">
<type class="Positive_regulation"/>
<theme idref="T20"/>
<clue><clueLoc>Hematopoietic tissues from these mice</clueLoc> display <clueType>elevated</clueType> levels of both <clueLoc>nuclear</clueLoc> NF-kappa B and mRNAs of some, but not all, genes thought to be regulated by NF-kappa B.</clue>
</event>
<event id="E7">
<type class="Positive_regulation"/>
<theme idref="T21" idref1="A3"/>
<clue><clueLoc>Hematopoietic tissues from these mice</clueLoc> display <clueType>elevated</clueType> levels of both nuclear NF-kappa B and mRNAs of some, but not all, genes thought to be regulated by NF-kappa B.</clue>
<comment>TPS: A3</comment></event>
<event CL="L2" KT="Analysis" id="E50" uncertainty="probable">
<type class="Regulation"/>
<theme idref="T21"/>
<cause idref="T22"/>
<clue>Hematopoietic tissues from these mice display elevated levels of both nuclear NF-kappa B and mRNAs of some, but not all, genes <clueKT><clueCL>thought</clueCL></clueKT> to be <clueType>regulated</clueType> <linkCause>by</linkCause> NF-kappa B.</clue>
</event>
<sentence id="S5"><term id="T23" lex="NF-kappa_B_elevation" sem="Other"><term id="T24" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> elevation</term> results in these <term id="T25" lex="phenotypic_abnormality" sem="Other">phenotypic abnormalities</term> because <term id="T26" lex="mice" sem="Multicellular_organism_natural">mice</term> lacking both <term id="T27" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> and the <term id="T28" lex="p50_subunit" sem="Protein_molecule">p50 subunit</term> of <term id="T29" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> show a dramatically delayed <term id="A6" sem="Other">onset of <term id="T30" lex="abnormality" sem="Other">abnormalities</term>.</term></sentence>
<event KT="Other" id="E8">
<type class="Positive_regulation"/>
<theme idref="T24"/>
<clue>NF-kappa B <clueType>elevation</clueType> results in these phenotypic abnormalities because mice lacking both I kappa B alpha and the p50 subunit of NF-kappa B show a dramatically delayed onset of abnormalities.</clue>
</event>
<event KT="Analysis" id="E9">
<type class="Positive_regulation"/>
<theme idref="E61"/>
<cause idref="E8"/>
<clue>NF-kappa B elevation <clueType><clueKT>results</clueKT></clueType> <linkTheme>in</linkTheme> <corefTheme>these phenotypic abnormalities</corefTheme> because mice lacking both I kappa B alpha and the p50 subunit of NF-kappa B show a dramatically delayed onset of abnormalities.</clue>
</event>
<event KT="Analysis" id="E10">
<type class="Positive_regulation"/>
<theme idref="E62"/>
<cause idref="E8"/>
<clue>NF-kappa B elevation <clueType><clueKT>results</clueKT></clueType> <linkTheme>in</linkTheme> <corefTheme>these phenotypic abnormalities</corefTheme> because mice lacking both I kappa B alpha and the p50 subunit of NF-kappa B show a dramatically delayed onset of abnormalities.</clue>
</event>
<event KT="Analysis" id="E11">
<type class="Positive_regulation"/>
<theme idref="E63"/>
<cause idref="E8"/>
<clue>NF-kappa B elevation <clueType><clueKT>results</clueKT></clueType> <linkTheme>in</linkTheme> <corefTheme>these phenotypic abnormalities</corefTheme> because mice lacking both I kappa B alpha and the p50 subunit of NF-kappa B show a dramatically delayed onset of abnormalities.</clue>
</event>
<event KT="Other" id="E13">
<type class="Negative_regulation"/>
<theme idref="T27"/>
<clue>NF-kappa B elevation results in these phenotypic abnormalities because <clueLoc>mice</clueLoc> <clueType>lacking</clueType> both I kappa B alpha and the p50 subunit of NF-kappa B show a dramatically delayed onset of abnormalities.</clue>
</event>
<event KT="Other" id="E51">
<type class="Negative_regulation"/>
<theme idref="T28"/>
<clue>NF-kappa B elevation results in these phenotypic abnormalities because <clueLoc>mice</clueLoc> <clueType>lacking</clueType> both I kappa B alpha and the p50 subunit of NF-kappa B show a dramatically delayed onset of abnormalities.</clue>
</event>
<event Manner="High" id="E14">
<type class="Negative_regulation"/>
<theme idref="A6"/>
<cause idref="E13"/>
<cause idref="E51"/>
<clue>NF-kappa B elevation results in these phenotypic abnormalities because mice lacking both I kappa B alpha and the p50 subunit of NF-kappa B show a <clueManner>dramatically</clueManner> <clueType>delayed</clueType> onset of abnormalities.</clue>
<comment>TPS: A6</comment></event>
<sentence id="S6">In contrast to <term id="T31" lex="hematopoietic_cell" sem="Cell_natural">hematopoietic cells</term>, <term id="T32" lex="I_kappa_B_alpha-/-_embryonic_fibroblast" sem="Cell_cultured"><term id="T33" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term>-/- embryonic fibroblasts</term> show minimal <term id="T34" lex="constitutive_NF-kappa_B" sem="Protein_molecule">constitutive <term id="T35" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term></term>, as well as normal <term id="A7" sem="Other">signal</term>-dependent <term id="T36" lex="NF-kappa_B_activation" sem="Other"><term id="T37" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activation</term> that is concomitant with <term id="T38" lex="I_kappa_B_beta_degradation" sem="Other"><term id="T39" lex="I_kappa_B_beta" sem="Protein_molecule">I kappa B beta</term> degradation</term>.</sentence>
<event id="E15">
<type class="Positive_regulation"/>
<theme idref="T37"/>
<cause idref="A7"/>
<clue>In contrast to hematopoietic cells, <clueLoc>I kappa B alpha-/- embryonic fibroblasts</clueLoc> show minimal constitutive NF-kappa B, as well as normal signal-<linkCause>dependent</linkCause> NF-kappa B <clueType>activation</clueType> that is concomitant with I kappa B beta degradation.</clue>
<comment>NER: T36 mod</comment></event>
<event id="E16">
<type class="Protein_catabolism"/>
<theme idref="T39"/>
<clue>In contrast to hematopoietic cells, I kappa B alpha-/- embryonic fibroblasts show minimal constitutive NF-kappa B, as well as normal signal-dependent NF-kappa B activation that is concomitant with I kappa B beta <clueType>degradation</clueType>.</clue>
</event>
<event id="E17">
<type class="Correlation"/>
<theme idref="E15"/>
<theme idref="E16"/>
<clue>In contrast to hematopoietic cells, I kappa B alpha-/- embryonic fibroblasts show minimal constitutive NF-kappa B, as well as normal signal-dependent NF-kappa B activation that is <clueType>concomitant</clueType> <linkTheme>with</linkTheme> I kappa B beta degradation.</clue>
</event>
<event id="E18">
<type class="Gene_expression"/>
<theme idref="T35"/>
<clue>In contrast to hematopoietic cells, <clueLoc>I kappa B alpha-/- embryonic fibroblasts</clueLoc> <clueType>show</clueType> minimal constitutive NF-kappa B, as well as normal signal-dependent NF-kappa B activation that is concomitant with I kappa B beta degradation.</clue>
</event>
<sentence id="S7">Our results indicate that <term id="A8" sem="Protein_molecule">I kappa b beta</term>, but not <term id="T40" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term>, is required for the <term id="A9" sem="Other">signal</term>-dependent <term id="T41" lex="activation" sem="Other">activation</term> of <term id="T42" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> in <term id="T43" lex="fibroblast" sem="Cell_natural">fibroblasts</term>.</sentence>
<event KT="Other" id="E19">
<type class="Positive_regulation"/>
<theme idref="T42"/>
<cause idref="A9"/>
<clue>Our results indicate that I kappa b beta, but not I kappa B alpha, is required for the signal-<linkCause>dependent</linkCause> <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B in fibroblasts.</clue>
<comment>NER: T41 mod</comment></event>
<event KT="Analysis" id="E20">
<type class="Positive_regulation"/>
<theme idref="E19"/>
<cause idref="A8"/>
<clue>Our results <clueKT>indicate</clueKT> that I kappa b beta, but not I kappa B alpha, is <clueType>required</clueType> <linkTheme>for</linkTheme> the signal-dependent activation of NF-kappa B <clueLoc>in fibroblasts</clueLoc>.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E21">
<type class="Positive_regulation"/>
<theme idref="E19"/>
<cause idref="T40"/>
<clue>Our results <clueKT>indicate</clueKT> that I kappa b beta, but <cluePolarity>not</cluePolarity> I kappa B alpha, is <clueType>required</clueType> <linkTheme>for</linkTheme> the signal-dependent activation of NF-kappa B <clueLoc>in fibroblasts</clueLoc>.</clue>
</event>
<sentence id="S8">However, <term id="T44" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> is required for the <term id="T45" lex="postinduction_repression" sem="Other">postinduction repression</term> of <term id="T46" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> in <term id="T47" lex="fibroblast" sem="Cell_natural">fibroblasts</term>.</sentence>
<event KT="Other" id="E22">
<type class="Negative_regulation"/>
<theme idref="T46"/>
<clue>However, I kappa B alpha is required for the <clueTime>postinduction</clueTime> <clueType>repression</clueType> <linkTheme>of</linkTheme> NF-kappa B in fibroblasts.</clue>
</event>
<event KT="Analysis" id="E23">
<type class="Positive_regulation"/>
<theme idref="E22"/>
<cause idref="T44"/>
<clue><clueKT>However</clueKT>, I kappa B alpha is <clueType>required</clueType> <linkTheme>for</linkTheme> the postinduction repression of NF-kappa B <clueLoc>in fibroblasts.</clueLoc></clue>
</event>
<sentence id="S9">These results define distinct roles for the two forms of <term id="T48" lex="I_kappa_B" sem="Protein_molecule">I kappa B</term> and demonstrate the necessity for stringent control of <term id="T49" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>.</sentence>
<event KT="Analysis" id="E24">
<type class="Regulation"/>
<theme idref="T49"/>
<cause idref="T48"/>
<clue>These results define distinct roles for the two forms of I kappa B and <clueKT>demonstrate</clueKT> the necessity for stringent <clueType>control</clueType> <linkTheme>of</linkTheme> NF-kappa B.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
